Tweets
Lisa Rider suggests that calcinosis is more commonly seen in JDM than adults maybe the result of the more prominent vasculopathy and IFN signature. #EULAR2022
Alberta Hoi @alberta_hoi ( View Tweet )
4 years 1 month ago
Always satisfying to see the big plenary hall in full flight #EULAR2022 @RheumNow https://t.co/DkzZCFvFw7
David Liew @drdavidliew ( View Tweet )
4 years 1 month ago
SLE trials update
Translating targeted therapy from bench to bedside has been more problematic in SLE than other autoimmune diseases.
https://t.co/xmYbgOplsm https://t.co/QUrtwAJqNl
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 1 month ago
Jacob van Laar on difficult to treat (D2T) RA. Comorbidities, fibromyalgia, obesity contribute to this. Associated with pauci-immune synovial pathotype. A consensus definition of D2T developed and est 5-20% of RA meet this criteria #EULAR2022 @RheumNow https://t.co/MgxJIJgxYw
Dr. Antoni Chan @synovialjoints ( View Tweet )
4 years 1 month ago
#EULAR2022 Difficult to treat RA (D2TRA):
Synovial pathotype shows a pauci-immune phenotype, different from other forms of RA
@RheumNow https://t.co/0osG5Bb5yb
Eric Dein @ericdeinmd ( View Tweet )
4 years 1 month ago
#EULAR2022 Difficult to treat RA
Which is the only independent risk factor in Netherlands study for D2TRA?
@RheumNow
Eric Dein @ericdeinmd ( View Tweet )
4 years 1 month ago
Those #EULAR2022 vaccination bracelets are not the most discrete of things (and you can’t take them off). https://t.co/02NrLcqzT2
Francois Nantel @FNantel ( View Tweet )
4 years 1 month ago
POS0130 from #EULAR2022 found only a 50% concordance between PsO patients with self-reported MSK pain and US findings of PsA. Remember, not all pain in PsO is PsA. @RheumNow https://t.co/CiMUa9HNgk
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 1 month ago
🦶🏼What drives positivity of famous Squeeze test in MTPs in RA?
MRI correlation study finds:
-in early RA, association w/
*Synovitis OR 3.2 and Inter-metatarsal bursitis OR 4.8
-in pts in remission
*Sub clinical synovitis only OR 2.5
@RheumNow #EULAR2022
OP0290 https://t.co/2CNUsaesaG
Aurelie Najm @AurelieRheumo ( View Tweet )
4 years 1 month ago
Prof van Lear defines Difficult to Treat (D2T) RA:
Failed >2 b/tsDMARD w/diff't MOA after failing csDMARD AND signs of active/progressing disease: DAS28 ESR >3.2 or CDAI>10, high ESR/CRP, imaging, Sx's causing low QoL, pred>7.5 mg/d, rapid xray progression #EULAR2022 @rheumnow
TheDaoIndex @KDAO2011 ( View Tweet )
4 years 1 month ago
Difficult to treat RA? #EULAR2022
1) Active/progressive disease, unable to taper steroids, radiographic progressive, decreased QoL
2) Failure of medications (2+ b/tsDMARD after csDMARD)
3) Physician/patient perception
- Fatigue: not part of definition
~5-20% pts
@Rheumnow https://t.co/i5sfwoF2Gs
Eric Dein @ericdeinmd ( View Tweet )
4 years 1 month ago
When will this madness stop!? TNFi to treat OA (yet again). Adalimumab for "inflammatory" knee OA. And again it doesn't work. @RheumNow #EULAR2022 OP0229 https://t.co/htwyLTYwG4
Links:
Richard Conway @RichardPAConway ( View Tweet )
4 years 1 month ago
